This is of importance because CD24 and CD44 have been implicated in HNSCC biology, with CD44 often considered a canonical cancer stem cell (CSC) marker, and the CD24+/CD44+ phenotype frequently investigated for its association with stemness, aggressive tumor behavior, and therapy resistance in HNSCC and other malignancies (18). This evidence concerns the gene CD24 and neoplasm.